PACAP regulation of central amygdala GABAergic synapses is altered by restraint stress

Neuropharmacology. 2020 May 15:168:107752. doi: 10.1016/j.neuropharm.2019.107752. Epub 2019 Aug 30.

Abstract

The pituitary adenylate cyclase-activating polypeptide (PACAP) system plays a central role in the brain's emotional response to psychological stress by activating cellular processes and circuits associated with threat exposure. The neuropeptide PACAP and its main receptor PAC1 are expressed in the rodent central amygdala (CeA), a brain region critical in negative emotional processing, and CeA PACAPergic signaling drives anxiogenic and stress coping behaviors. Despite this behavioral evidence, PACAP's effects on neuronal activity within the medial subdivision of the CeA (CeM, the major output nucleus for the entire amygdala complex) during basal conditions and after psychological stress remain unknown. Therefore, in the present study, male Wistar rats were subjected to either restraint stress or control conditions, and PACAPergic regulation of CeM cellular function was assessed using immunohistochemistry and whole-cell patch-clamp electrophysiology. Our results demonstrate that PACAP-38 potentiates GABA release in the CeM of naïve rats, via its actions at presynaptic PAC1. Basal PAC1 activity also enhances GABA release in an action potential-dependent manner. Notably, PACAP-38's facilitation of CeM GABA release was attenuated after a single restraint stress session, but after repeated sessions returned to the level observed in naïve animals. A single restraint session also significantly decreased PAC1 levels in the CeM, with repeated restraint sessions producing a slight recovery. Collectively our data reveal that PACAP/PAC1 signaling enhances inhibitory control of the CeM and that psychological stress can modulate this influence to potentially disinhibit downstream effector regions that mediate anxiety and stress-related behaviors. This article is part of the special issue on 'Neuropeptides'.

Keywords: Anxiety; GABA; PAC1; PACAP-38; Pituitary adenylate cyclase-activating polypeptide; Synaptic transmission; sIPSC.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Central Amygdaloid Nucleus / drug effects
  • Central Amygdaloid Nucleus / metabolism*
  • GABAergic Neurons / drug effects
  • GABAergic Neurons / metabolism*
  • Inhibitory Postsynaptic Potentials / drug effects
  • Inhibitory Postsynaptic Potentials / physiology
  • Male
  • Pituitary Adenylate Cyclase-Activating Polypeptide / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / metabolism
  • Restraint, Physical / adverse effects
  • Restraint, Physical / psychology
  • Stress, Psychological / metabolism*
  • Stress, Psychological / psychology
  • Synapses / drug effects
  • Synapses / metabolism*
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • gamma-Aminobutyric Acid